Parimifasor
|
PARIMIFASOR
|
1796641-10-5
|
Protein Kinase Inhibitors 1
|
1365986-44-2
|
1365986-44-2
|
E260
|
1241537-79-0
|
1241537-79-0
|
b-Nicotinamide adenine dinucleotide phosphate disodium salt
|
beta-煙酰胺腺嘌呤二核苷酸磷酸二鈉鹽
|
24292-60-2
|
DBeQ
|
DBEQ
|
177355-84-9
|
β-Nicotinamide Mononucleotide
|
β-煙酰胺單核苷酸
|
1094-61-7
|
(R,S)-Palonosetron HCl
|
RS-鹽酸帕洛諾司瓊
|
135755-51-0
|
NADH (disodium salt)
|
beta-煙酰胺腺嘌呤二核苷二鈉
|
606-68-8
|
Ketoconazole EP Impurity C
|
酮康唑雜質(zhì)C
|
83374-59-8
|
Labetalol Impurity A
|
拉貝洛爾雜質(zhì)A
|
1391051-99-2
|
N-Formyl-L-kynurenine
|
N'-甲?;?L-尿嘧啶
|
3978-11-8
|
5-Fluoro-2'-deoxyuridine-5'-triphosphate (triethylammonium salt form)
|
|
1621676-99-0
|
Naratriptan Hydrochloride
|
鹽酸那拉曲坦
|
143388-64-1
|
Rac-cis-Sertraline Hydrochloride
|
RAC-CIS-舍曲林
|
79617-95-1
|
Tariquidar
|
N-[2-[[4-[2-(6,7-二甲氧基-3,4-二氫-1H-異喹啉-2-基)乙基]苯基]氨基甲?;鵠-4,5-二甲氧基苯基]喹啉-3-甲酰胺
|
206873-63-4
|
Levothyroxine EP Impurity J
|
3,3'-二碘甲腺原氨酸
|
4604-41-5
|
Omeprazole
|
奧美拉唑
|
73590-58-6
|
Quetiapine Impurity F (11-Chlorodibenzo[b,f][1,4]thiazepine)
|
11-氯-二苯并[b,f][1,4]硫氮雜卓
|
13745-86-3
|
Palonosetron N-Oxide
|
帕洛諾司瓊N氧化物
|
813425-83-1
|
Detrothyronine
|
D-T3
|
5714-08-9
|
4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenaminehydrochloride
|
4-(3,4-二氯苯基)-1,2,3,4-四氫-N-甲基-1-萘胺鹽酸鹽
|
79617-89-3
|
4-Desmethoxy Omeprazole Sulfide
|
2-[[(3,5-二甲基-2-吡啶基)甲基]硫基]-5-甲氧基-1H-苯并咪唑
|
704910-89-4
|
N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride
|
11-哌嗪-二苯并[b,f][1,4]硫氮雜卓鹽酸鹽
|
111974-74-4
|
(R)-Omeprazole Sodium Salt
|
5-甲氧基-2-[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基]-3H-苯并咪唑鈉鹽
|
161796-77-6
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide hydrochloride
|
尼達(dá)尼布雜質(zhì)
|
2037385-84-3
|
N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide
|
N,4-二甲基-N-(4-硝基苯基)-1-哌嗪乙酰胺
|
1139453-98-7
|
SHP099 HCl
|
SHP-099鹽酸鹽
|
1801747-11-4
|
Rivaroxaban EP Impurity I
|
利伐沙班雜質(zhì)J
|
1151893-81-0
|
Omeprazole Related Compound 10
|
奧美拉唑雜質(zhì)
|
142885-92-5
|
(±)-Anatabine
|
新煙草堿(去氫新煙堿)
|
2743-90-0
|
RGW 611
|
4-(2-(4-NITRO-1H-IMIDAZOL-1-YL)ETHYL)MORPHOLINE
|
6497-78-5
|
4-Hydroxy Omeprazole Sodium Salt
|
2-(((3,5-二甲基-4-氧化吡啶-2-基)甲基)亞磺?;?-5-甲氧基苯并[d]咪唑-1-鈉
|
1803449-15-1
|
(S)-2-(2-((4-(5-((5-Chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid hydrochloride
|
利伐沙班雜質(zhì)25
|
931117-61-2
|
6-Bromo-8-cyclopentyl-2-[[5-(4-Boc-1-piperazinyl)-2-pyridyl]amino]-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
|
帕布昔利布雜質(zhì)23
|
571188-82-4
|
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
|
尼洛替尼雜質(zhì)
|
641571-16-6
|
4-(2,4-Diaminophenyl)morpholin-3-one
|
利伐沙班雜質(zhì)21
|
482308-13-4
|
Methyl 1-Acetyl-2-oxoindoline-6-carboxylate
|
1-乙?;?2,3-二氫-2-氧代-1H-吲哚-6-羧酸甲酯
|
676326-36-6
|
Olaparib
|
奧拉帕尼
|
763113-22-0
|
7-Troc-paclitaxel
|
7-(2,2,2-三氯乙基氧基羰基)紫杉醇
|
114915-17-2
|
Paclitaxel EP Impurity H
|
7-表-10-去乙酰基云南紫杉寧A
|
78454-17-8
|
Rivaroxaban EP Impurity J
|
利伐沙班開環(huán)二聚體
|
1632463-24-1
|
5-bromo-4-chloro-N-cyclopentylpyrimidin-2-amine
|
帕布昔利布雜質(zhì)
|
1823404-28-9
|
1,4-Bis(4-nitrophenyl)piperazine
|
1,4-雙(4-硝基苯基)哌嗪
|
16264-05-4
|
6-Desacetyl-6-Bromo Palbociclib
|
PALBOCICLIB雜質(zhì)A
|
851067-56-6
|
Tert-butyl 4-(6-((6-(1-butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
|
2-甲基-2-丙基-4-(6 - {[8-環(huán)戊基-5-甲基-7-氧代-6-(1-丁氧乙烯基)-7,8-二氫吡啶并[2,3-D]嘧啶-2-基]氨基} -3-吡啶基)-1-哌嗪甲酸
|
866084-31-3
|
tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
|
帕布昔利布雜質(zhì)X
|
571189-65-6
|
Pemetrexed Impurity E Disodium Salt
|
培美曲塞雜質(zhì)E
|
937370-10-0
|
SPHINX31
|
CS-2837
|
1818389-84-2
|
GSK-2018682
|
CPD1224
|
1034688-30-6
|
WEHI-345
|
N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺
|
1354825-58-3
|
GSK2982772
|
GSK2982772
|
1622848-92-3
|
RBC8
|
RBC8
|
361185-42-4
|
Tenapanor
|
CS-2459
|
1234423-95-0
|
1-Methylpyridin-1-ium-2-carboxamide
|
氯解磷定
|
45750-74-1
|
Dicresulene
|
地瑞舒林
|
78480-14-5
|
BAR-501
|
CPDD0945
|
1632118-69-4
|
Paliperidone Palmitate
|
棕櫚酸帕利哌酮
|
199739-10-1
|
2,5-Dioxopyrrolidine Sacubitril
|
原研550-06
|
1038924-97-8
|
Safinamide Impurity 8
|
沙芬酰胺雜質(zhì)8
|
690969-16-5
|
Rivastigmine USP Related Compound F
|
N-乙基-N-甲基-3-乙烯苯基氨基甲酸酯
|
1346602-84-3
|
Pidotimod Impurity Y
|
匹多莫德雜質(zhì)Y
|
161771-76-2
|
N-2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethylsilodosin
|
西洛多辛雜質(zhì)19
|
1453221-45-8
|
Nimesulide Impurity F
|
N-(甲基磺?;?-4'-硝基-2'-苯氧基甲烷磺酰苯胺
|
51765-72-1
|
Tenofovir Disoproxil USP Related Compound H
|
替諾福韋氨基甲酸酯
|
1244022-54-5
|
((R)-2-Biphenyl-4-yl-1-formylethyl)carbamic Acid t-Butyl Ester
|
AHU-377中間體2
|
149709-58-0
|
Sitagliptin styrylacetyl analog
|
西格列汀雜質(zhì)
|
1803026-58-5
|
Sitagliptin phenylcrotonyl analog
|
西格列汀雜質(zhì)05
|
1253056-18-6
|
(3R,5S)-5-Biphenyl-4-ylmethyl-3-methylpyrrolidin-2-one
|
LCZ696中間體1
|
1038924-70-7
|
(2R)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide
|
沙芬酰胺對映異構(gòu)體
|
174756-44-6
|
Sparsentan (RE-021)
|
司帕生坦
|
254740-64-2
|
Enalapril EP Impurity D
|
依那普利二酮哌嗪
|
115729-52-7
|
Nimesulide Impurity E
|
N-(甲基磺?;?-N-(2-苯氧基苯基)甲烷磺酰胺
|
905858-63-1
|
Safinamide Impurity 5
|
沙芬酰胺雜質(zhì)5
|
1160513-60-9
|
Sofosbuvir Impurity (GS-566500)
|
N-[(2'R)-2'-脫氧-2'-氟-2'-甲基-5'-尿苷?;鵠-L-丙氨酸
|
1233335-78-8
|
(3alpha,5beta,6beta,7alpha)-6-Ethylcholane-3,7,24-triol
|
BAR 501 IMPURITY
|
1632118-70-7
|
Sitagliptin Fumarate Adduct (Mixture of Diastereomers)
|
西他列汀雜質(zhì)21
|
2088771-60-0
|
Clopidogrel Related Compound B
|
氯吡咯雷雜質(zhì)B
|
144750-52-7
|
Humulone
|
律草酮
|
26472-41-3
|
Pidotimod Impurity X
|
匹多莫德雜質(zhì)X
|
161771-75-1
|
Clopidogrel EP Impurity A
|
氯吡格雷酸
|
144457-28-3
|
Lepirudin
|
來匹盧定
|
138068-37-8
|
Ethyl 3,5-bis(benzyloxy)benzoate
|
特布他林雜質(zhì)
|
50841-46-8
|
2-Bromo-3',5'-dibenzyloxyacetphenone
|
2-溴-3'.5'-二芐氧基苯乙酮
|
28924-18-7
|
1-(3,5-bis(benzyloxy)phenyl)-2-(tert-butylamino)ethanone
|
硫酸特比萘芬雜質(zhì)J
|
52144-90-8
|
Benzyl 3,5-bis(phenylmethoxy)benzoate
|
特布他林雜質(zhì)
|
50513-72-9
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone sulfate (2:1)
|
特布他林雜質(zhì)
|
52144-93-1
|
2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethanone
|
特布他林雜質(zhì)4
|
52144-92-0
|
Tenofovir Related Compound 1
|
替諾福韋拉酚氨酯雜質(zhì)04
|
342631-41-8
|
Tetracaine Impurity C
|
4-丁氨基苯甲酸甲酯
|
71839-12-8
|
Salirasib
|
法尼基硫代水楊酸
|
162520-00-5
|
6-Desacetyl Palbociclib Hydrochloride
|
帕布昔利布雜質(zhì)20
|
571189-66-7
|
FMK
|
FMK
|
821794-92-7
|
N-Acetyl Sitagliptin
|
1379666-94-0
|
N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine
|
替諾福韋雜質(zhì)134
|
376633-24-8
|
MTIC
|
3-甲基(三氮雜烯基)咪唑-4 甲酰胺
|
3413-72-7
|
Bisoprolol EP Impurity L hydrochloride
|
鹽酸美托洛爾雜質(zhì)3
|
1956321-87-1
|
Pabociclib Impurity B Hydrochloride
|
帕布昔利布雜質(zhì)
|
1883672-48-7
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide
|
尼達(dá)尼布雜質(zhì)
|
1038972-16-5
|
Ketotifen Impurity B
|
10-甲氧基-4-(1-甲基-4-哌啶基)-4H-苯并[4,5]環(huán)庚三烯并[1,2-B]噻吩-4-醇
|
59743-88-3
|
GGTI-298
|
GGTI-298
|
180977-44-0
|